HQL: abrdn Life Sciences Investors

Performance

HQL +14.68%

Watchlist

Select an item

RETURNS1DYTD1Y5Y Ann.Max DDSharpeDiv. Yield
HQL-0.74%+14.39%+14.68%+8.30%-23.87%0.5312.81%

Summary

HQL at a glance

HQL returned +14.68% over the past year and +8.30% a year over five years. Its worst drop in that year was -23.87%, smaller than 7% of closed-end funds on Redstone, and its Sharpe ratio of 0.53 beats 81% of closed-end funds on Redstone. It yields 12.81%.

Ranking

How HQL ranks

86
1Y Return Rank
86
5Y Return Rank
81
Sharpe Ratio Rank
7
Max Drawdown Rank
8
Volatility Rank
75
Dividend Yield Rank

Current Drawdown

-20.65%

Rolling Volatility

35.17%

Dividends

HQL dividends

Yield

12.81%

Paid, past year

$2.24

Pays

Quarterly

Growth a year

+10.2%

Per share, by year

2022
$1.36
2023
$1.27
2024
$1.86
2025
$1.82
Past year
$2.24

Yearly return over 5 years

With dividends+8.30%
Price only-3.13%
From dividends+11.43 pts

HQL paid $2.24 a share over the past year, every quarter. Its yearly rate rose from $1.36 in 2022 to $1.82 in 2025, 10.2% a year. With dividends reinvested it returned +8.30% a year over five years, against -3.13% on price alone.

›All 20 payments since Nov 23, 2021
  • Aug 24, 2026$0.62
  • May 21, 2026$0.56
  • Feb 20, 2026$0.56
  • Nov 21, 2025$0.50
  • Aug 22, 2025$0.42
  • May 22, 2025$0.43
  • Feb 21, 2025$0.47
  • Nov 21, 2024$0.50
  • Aug 23, 2024$0.49
  • May 22, 2024$0.48
  • Feb 21, 2024$0.39
  • Nov 21, 2023$0.30
  • Aug 24, 2023$0.32
  • May 24, 2023$0.32
  • Feb 24, 2023$0.33
  • Nov 23, 2022$0.31
  • Aug 25, 2022$0.31
  • May 26, 2022$0.35
  • Feb 24, 2022$0.39
  • Nov 23, 2021$0.42
Actions

Metrics

Risk Indicators

Alpha5.45%
Beta0.90x
Sharpe0.53
Sortino0.78
Omega1.09
Calmar0.61
Martin1.56

Profile

About HQL

The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of life sciences companies.

From its annual report, filed Dec 8, 2025
Category
Health Care
Expense ratio
1.24%
Market cap
$532M
Listed
May 1992